Trending...
- COVID-19 Omicron variant illustrates importance of getting vaccinated, including booster doses, wearing masks, other mitigation strategies; MDHHS is monitoring to identify any presence in Michigan, but has not yet detected new variant
- Michigan: PHOTOS: MDARD Director Gary McDowell Celebrates Small Business Saturday with Kluck Nursery
- Governor Whitmer Announces 16 Communities to Receive Additional Funding to Invest in Local Parks and Trails throughout Michigan
CANTON, Mich.--(BUSINESS WIRE)--MMS Holdings – a data-focused CRO – announced this week the addition of Kevin Chartier, Ph.D., as Principal Advisor of Biostatistics and Submissions Planning. Chartier will work with the biostatistics team across MMS global operations to support Sponsors with complex studies and submissions.
Bringing more than 25 years of statistics experience, Dr. Chartier has held positions at Astellas Pharma, Novartis, Wyeth, Pfizer, and United BioSource Corporation across various statistics, biometrics, and biostatistics functions. In addition, he completed his Ph.D. in Statistics from Kansas State University.
"At MMS, we pride ourselves on being able to provide our Sponsors with the right experts to meet their goals," said Michelle Gayari, Executive Vice President, Global Operational Excellence and Innovation, MMS. "With the addition of Dr. Chartier and his extensive experience in biostatistics and submissions planning to our global team, we continue to build on our best-in-class clinical trial design and data solutions for Sponsors and patients."
Dr. Chartier's responsibilities as Principal Advisor of Biostatistics and Submissions Planning include:
"I am excited to join an organization with a proven track record, being able to get closer to the science and the data, and consulting with other drug developers," said Dr. Kevin Chartier. "I plan on building upon this success and strive to provide MMS Sponsors with innovative fit-for-purpose quantitative development strategies and study options to ensure optimal decision making. I'm looking forward to providing educational opportunities for MMS colleagues and Sponsors who desire these services as well."
More on Michimich.com
Additionally, Dr. Chartier will continue his mission of ensuring statistical and quantitative experts are full drug development partners shaping the evolution of drug development.
MMS was recently named a Detroit Free Press Top Workplace in 2021.
Learn more about MMS at www.mmsholdings.com/
About MMS Holdings
MMS is an award-winning, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the company was named Most Outstanding CRO in the 2019 Biotechnology Awards and was named a Detroit Free Press Top Workplace in 2021.
For more information, visit www.mmsholdings.com or follow MMS on LinkedIn.
More on Michimich.com
Contacts
Media Contact
Avery Zimmerman
734-738-5055
media@mmsholdings.com
Bringing more than 25 years of statistics experience, Dr. Chartier has held positions at Astellas Pharma, Novartis, Wyeth, Pfizer, and United BioSource Corporation across various statistics, biometrics, and biostatistics functions. In addition, he completed his Ph.D. in Statistics from Kansas State University.
"At MMS, we pride ourselves on being able to provide our Sponsors with the right experts to meet their goals," said Michelle Gayari, Executive Vice President, Global Operational Excellence and Innovation, MMS. "With the addition of Dr. Chartier and his extensive experience in biostatistics and submissions planning to our global team, we continue to build on our best-in-class clinical trial design and data solutions for Sponsors and patients."
Dr. Chartier's responsibilities as Principal Advisor of Biostatistics and Submissions Planning include:
- Acting as the senior technical reviewer for complex biostatistics studies
- Advising Sponsors on biostatistics methods and efficiencies for health authority submissions
- Contributing to MMS' emerging biometrics service areas, data science using real world evidence and built-for-purpose technology, Datacise™ , adaptive trial design, and decentralized clinical trials (DCTs)
- Leading complex biostatistics studies, programs and submissions across therapeutic areas and extending to rare diseases
"I am excited to join an organization with a proven track record, being able to get closer to the science and the data, and consulting with other drug developers," said Dr. Kevin Chartier. "I plan on building upon this success and strive to provide MMS Sponsors with innovative fit-for-purpose quantitative development strategies and study options to ensure optimal decision making. I'm looking forward to providing educational opportunities for MMS colleagues and Sponsors who desire these services as well."
More on Michimich.com
- Xoran's VetCAT 3D CT Imaging Implemented at Chicago Exotics Animal Hospital
- Michigan: MDARD Issues Consumer Advisory for Certain Enoki Mushrooms
- Michigan: AG Nessel Issues Statement on New Charges in Oxford High School Shooting
- Michigan: State Leaders React to Federal Plan to Increase Access to COVID-19 Testing to Battle COVID-19 this Winter
- Option traders think Hertz stock could reach $30 soon
Additionally, Dr. Chartier will continue his mission of ensuring statistical and quantitative experts are full drug development partners shaping the evolution of drug development.
MMS was recently named a Detroit Free Press Top Workplace in 2021.
Learn more about MMS at www.mmsholdings.com/
About MMS Holdings
MMS is an award-winning, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the company was named Most Outstanding CRO in the 2019 Biotechnology Awards and was named a Detroit Free Press Top Workplace in 2021.
For more information, visit www.mmsholdings.com or follow MMS on LinkedIn.
More on Michimich.com
- NAC Applauds Federal Bank Regulators for Updating & Clarifying BSA/AML Examination Manual Section on Banking of Independent ATM Companies
- Michigan: MDHHS updates school guidance quarantine guidelines, continues to strongly recommend universal masking to prevent spread of COVID-19
- Michigan: Eligible Municipalities Encouraged to Register for Participation in Historic Opioid Settlement
- MSG's Web Design Year in Review
- NSG Spills the Truth About Wix
Contacts
Media Contact
Avery Zimmerman
734-738-5055
media@mmsholdings.com
Filed Under: Business
0 Comments
Latest on Michimich.com
- EA Sports and Activision Former VP Kim Salzer Steps in as CMO for NFT Gaming Social Impact Ecosystem Original Gamer Life
- Michigan Indigent Defense Commission Selects Kristen Staley as Executive Director
- Michigan: Grant funding to help low-income customers pay home heating bills announced for 2021-2022
- State of Michigan secures additional federal team to assist Covenant HealthCare in Saginaw with staffing
- Avert Holiday Anxiety and Depression with Self-Care
- Construction Tool & Supply of Warren, MI Acquired by Individual Investor
- DC Norris North America Offers Cash-Back Rebate on New Commercial Sous Vide Cook Tank
- California Air Resources Board Chair Liane Randolph to present keynote address at Green Truck Summit
- Michigan: AG Nessel Shares Giving Reminders Following Oxford High School Tragedy
- Michigan: Gov. Whitmer Announces 40 High-Wage Jobs as Global Auto Supplier TÜV SÜD America Establishes State-of-the-Art EV Battery Testing Facility in Auburn Hills
- Unvaccinated residents filling Michigan hospitals, getting hospitalized for COVID
- Michigan: Secretary Benson brings back the "Water-Winter Wonderland" license plate
- Toolfetch Hosts Product Launch for the New LB White Premier 40 Tent Heater
- STRANGE DEVELOPMENT--A Startup Engineering Company -Awarded $1 Million National Science Foundation Phase II Grant
- PHOTO RELEASE: MDARD Director Gary McDowell Highlights Consumer Protections that Puts Michiganders First this Holiday Season
- LaChance Brothers Excavating Discuss the Impacts of Garbage Disposals
- Give the Gift That Sparkles All Year Long – Drinkmate
- Delights Discusses Origins of Christmas Decorations
- Data Accuracy Revolution Begins: Truthset wins I-COM Challenge
- Create a Unique Summer Camp Experience with an Aluminum Boat Dock from Alumi-Span Docks